Yeast Surface-Displayed H5N1 Avian Influenza Vaccines

Figure 5

Immune protection conferred by EBY100/pYD1-HA against lethal challenge with homologous H5N1 virus. (a-b) Clinical score on the intramuscularly (i.m.) or intraperitoneally (i.p.) vaccinated mice at 7 days after challenge and (c-d) weight change as a percentage on the intramuscularly (i.m.) or intraperitoneally (i.p.) vaccinated mice after challenge.

(a)

(b)

(c)

(d)